Filament CEO Ben Lightburn was interviewed by the Associated Press and explained why Filament is focused on extracting compounds like psilocybin and mescaline from natural sources, like magic mushrooms and cacti, rather than synthesizing them.
Recent News
In crowded field of psychedelic startups, Filament CEO makes case for ‘natural’ drugs
The Associated Press
November 13, 2023
